Abstract
Background: Breast cancer is the most commonly diagnosed cancer among women worldwide with limited treatment options. Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) is one of the main constituents of Brazilian propolis presenting different activities, including antitumoral effects against various types of cancer.
Objective: We evaluated the antitumoral potential and mechanisms of action of artepillin C against two distinct human breast cancer cell lines, MCF-7 and MDA-MB-231, to explore a new therapeutic candidate.
Methods: Cell viability was assessed by MTT assay and the long-term cytotoxicity was performed by clonogenic assay. The morphological changes were observed by light microscopy, analysis of cell death pathway by Annexin V FITC/propidium iodide (PI), lactate dehydrogenase (LDH) by colorimetry, DNA fragmentation by agarose gel and senescence by β-galactosidase. Detection of total reactive oxygen species (ROS) by fluorescence microscopy and determination of mitochondrial transmembrane potential by flow cytometry were also performed.
Results: Artepillin C presented a strong and dose-time-dependent cytotoxic effect on MCF-7 and MDA-MB-231 cell lines, with cytotoxicity more evident in MCF-7. In both cancer cell lines, the clonogenic potential was significantly reduced and the morphology of the cells was changed. The treatment also induced death by necrosis and late apoptosis in MCF-7 and MDA-MB-231 and induced cell senescence in MCF-7. Also, artepillin C increased total ROS in both cancer cells and decreased mitochondrial membrane potential in MDA-MB-231 cells.
Conclusion: Artepillin C presented antitumoral potential in two human breast cancer cell lines, MCF-7, and MDA-MB-231, suggesting a new promising option for the treatment and/or chemopreventive strategy for breast cancer.
Graphical Abstract
[http://dx.doi.org/10.1007/s13304-017-0424-1] [PMID: 28260181]
[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338]
[http://dx.doi.org/10.1186/s12889-015-1346-9] [PMID: 25636332]
[http://dx.doi.org/10.1016/S0140-6736(16)31891-8] [PMID: 27865536]
[http://dx.doi.org/10.4103/1119-3077.94088] [PMID: 22437080]
[http://dx.doi.org/10.1038/nrc1670] [PMID: 16056258]
[http://dx.doi.org/10.1080/87559129.2019.1649692]
[http://dx.doi.org/10.1016/j.phrs.2021.105759] [PMID: 34245864]
[http://dx.doi.org/10.1016/j.biopha.2021.112364] [PMID: 34700230]
[http://dx.doi.org/10.1111/jam.13400] [PMID: 28066967]
[http://dx.doi.org/10.1002/ptr.2658] [PMID: 19003952]
[http://dx.doi.org/10.1016/j.ejphar.2008.02.067] [PMID: 18474366]
[http://dx.doi.org/10.2174/1871520618666180604092930] [PMID: 29866020]
[http://dx.doi.org/10.1038/bjc.1987.190] [PMID: 3663476]
[http://dx.doi.org/10.1038/nprot.2006.339] [PMID: 17406473]
[http://dx.doi.org/10.1016/j.lfs.2020.117858] [PMID: 32497635]
[http://dx.doi.org/10.1016/j.ab.2005.06.003] [PMID: 16004951]
[http://dx.doi.org/10.21769/BioProtoc.374] [PMID: 27430005]
[http://dx.doi.org/10.1007/s10571-018-0623-4] [PMID: 30302629]
[http://dx.doi.org/10.1002/mc.20148] [PMID: 16224795]
[http://dx.doi.org/10.1016/j.phymed.2014.04.006] [PMID: 24854570]
[http://dx.doi.org/10.1101/pdb.prot095497] [PMID: 29858337]
[http://dx.doi.org/10.1016/j.jphotobiol.2016.11.006] [PMID: 27889618]
[http://dx.doi.org/10.1038/ncb1567] [PMID: 17450133]
[http://dx.doi.org/10.1002/jcb.10320] [PMID: 12461777]
[http://dx.doi.org/10.1089/ars.2008.2104] [PMID: 18976161]
[http://dx.doi.org/10.1074/jbc.M205477200] [PMID: 12101184]
[http://dx.doi.org/10.1080/09553000500168549] [PMID: 16308915]
[http://dx.doi.org/10.1038/s41523-019-0108-8] [PMID: 30993194]
[http://dx.doi.org/10.1016/j.bmc.2021.116372] [PMID: 34454129]